CS
MED icon

Cannell & Spears’s Medifast MED Stock Holding History

Cannell & Spears’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,571
Closed -$284K – 205
2022
Q2 		$284K Sell
1,571
-5
-0.3% -$895 0.03% 175
2022
Q1 		$269K Buy
+1,576
New +$297K 0.02% 192
2021
Q3 		– Sell
-783
Closed -$222K – 247
2021
Q2 		$222K Buy
+783
New +$212K 0.02% 222
2020
Q3 		– Sell
-1,897
Closed -$263K – 238
2020
Q2 		$263K Buy
+1,897
New +$174K 0.03% 173

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return